Sanofi and GSK to seek regulatory authorization for COVID-19 vaccine
Final analysis of the global VAT02 booster trial confirms universal ability to boost neutralizing antibodies 18- ...
Read moreFinal analysis of the global VAT02 booster trial confirms universal ability to boost neutralizing antibodies 18- ...
Read moreGSK and Vir announce sotrovimab receives Emergency Use Authorization from the US FDA for treatment of ...
Read moreOpinion based on the EMA’s Committee for Human Medicinal Products (CHMP) review of available data on ...
Read moreSimilar antibody response in adults and in the elderly after two doses Neutralizing antibody responses were ...
Read moreGlaxoSmithKline plc announced the European Commission has approved the expanded use of intravenous and subcutaneous BENLYSTA ...
Read moreViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. ...
Read moreStrong growth in new pharmaceutical products offset by stocking and pandemic disruption Pharmaceuticals £3.9 billion -12% ...
Read moreU.S. Food and Drug Administration granted accelerated approval to Jemperli (dostarlimab) for treating patients with recurrent ...
Read moreGSK Consumer Healthcare the maker of Advil, today announced its commitment to reducing the plastic in ...
Read moreGlaxoSmithKline plc and Vir Biotechnology, Inc. today announced that the European Medicines Agency (EMA) has started ...
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.